Transcript segment

Baric Transcribed Interview (Redacted), p.111 · baric_ti:utt:00957

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric

Besides the NIH? I mean, technically, the work that we did with MERS, where we were given a waiver, as far as I know it was never really reviewed for GOF. It decided that it was in the national interest to develop a mouse model so that countermeasures could be developed against MERS. The virus has a 35 percent mortality rate. It could transmit to people, and it could transmit through asymptomatic spread. So there's a threat potential there. I think NIH made the right call in that case, that you develop the appropriate reagents so that you can move countermeasures forward to protect the public.

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

For DARPA? No.
2026-04-10 09:00 Christina Salazar open

For DoD?
2026-04-10 09:00 Ralph S. Baric open

No.
2026-04-10 09:00 Christina Salazar open

For any other Federal agency?
2026-04-10 09:00 Ralph S. Baric

Besides the NIH? I mean, technically, the work that we did with MERS, where we were given a waiver, as far as I know it was never really reviewed for GOF. It decided that it was in the national interest to develop a mouse model so that countermeasures could be developed against MERS. The virus has a 35 percent mortality rate. It could transmit to people, and it could transmit through asymptomatic spread. So there's a threat potential there. I think NIH made the right call in that case, that you develop the appropriate reagents so that you can move countermeasures forward to protect the public.
2026-04-10 09:00 Christina Salazar open

Okay. So have you ever done gain-of22 function research under any other federally funded grant?
2026-04-10 09:00 Ralph S. Baric open

No.
2026-04-10 09:00 Christina Salazar open

Have you ever, you know, created a virus or provided sequences or done something under a contract DC.Scheduling@LexitasLegal.com where you were not the one that was actually conducting gain-of-function research, but the overarching experimental research was --
2026-04-10 09:00 Ralph S. Baric open

Can you put that into a direct example, rather than this global thing that requires me to remember everything that I did in the last 40 years of my life?

Full conversation →